National Health Investors Inc. Files 10-Q for Q1 2024

TL;DR

<b>National Health Investors Inc. filed its Q1 2024 10-Q, detailing financial performance and operational segments.</b>

AI Summary

NATIONAL HEALTH INVESTORS INC (NHI) filed a Quarterly Report (10-Q) with the SEC on May 6, 2024. National Health Investors Inc. filed its 10-Q report for the period ending March 31, 2024. The filing covers the first quarter of 2024, with data compared to previous periods. Key financial statement elements such as common stock, additional paid-in capital, and retained earnings are detailed. The company operates within the Real Estate Investment Trusts sector. Segments include Senior Housing Communities, Skilled Nursing Facilities, Hospitals, and Independent Living Facilities.

Why It Matters

For investors and stakeholders tracking NATIONAL HEALTH INVESTORS INC, this filing contains several important signals. This 10-Q provides investors with the latest financial snapshot of National Health Investors Inc., crucial for understanding its current performance and strategic positioning. The detailed segment information allows for an analysis of which areas of the healthcare real estate market are contributing most significantly to the company's operations.

Risk Assessment

Risk Level: low — NATIONAL HEALTH INVESTORS INC shows low risk based on this filing. The filing is a standard quarterly report (10-Q) with no immediate red flags or significant negative disclosures, indicating a routine update.

Analyst Insight

Monitor future filings for trends in revenue growth and net income across NHI's various healthcare real estate segments.

Revenue Breakdown

Key Numbers

• 2024-03-31 — Report Date (Conformed Period of Report)
• 2024-05-06 — Filing Date (Filed as of Date)
• 2024-01-01 — Quarter Start Date (2024 Q1)
• 2023-03-31 — Prior Year Q1 End Date (2023 Q1)

Key Players & Entities

• NATIONAL HEALTH INVESTORS INC (company) — Filer
• 0000877860 (company) — Central Index Key
• 6798 (regulator) — Standard Industrial Classification Code
• MD (company) — State of Incorporation
• 222 ROBERT ROSE DRIVE (company) — Business Address Street 1
• MURFREESBORO (company) — Business Address City
• TN (company) — Business Address State
• 37129 (company) — Business Address ZIP

FAQ

Key Dates

• 2024-03-31: Quarter End Date — End of the reporting period for the 10-Q filing.
• 2024-05-06: Filing Date — Date the 10-Q was officially submitted to the SEC.

Key Financial Figures

• $0.01 — ange on which registered Common Stock, $0.01 par value NHI New York Stock Exchange

Filing Documents

• nhi-20240331.htm (10-Q) — 1637KB
• nhi-3312024x10qex311.htm (EX-31.1) — 11KB
• nhi-3312024x10qex312.htm (EX-31.2) — 11KB
• nhi-3312024x10qex32.htm (EX-32) — 8KB
• 0000877860-24-000047.txt (&nbsp;) — 9183KB
• nhi-20240331.xsd (EX-101.SCH) — 82KB
• nhi-20240331_cal.xml (EX-101.CAL) — 84KB
• nhi-20240331_def.xml (EX-101.DEF) — 401KB
• nhi-20240331_lab.xml (EX-101.LAB) — 822KB
• nhi-20240331_pre.xml (EX-101.PRE) — 634KB
• nhi-20240331_htm.xml (XML) — 1188KB

Financial Information

Part I. Financial Information

Financial Statements

Item 1. Financial Statements 3

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. 28

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk. 51

Controls and Procedures

Item 4. Controls and Procedures. 52

Other Information

Part II. Other Information

Legal Proceedings

Item 1. Legal Proceedings 53

Risk Factors

Item 1A. Risk Factors 53

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 53

Other Information

Item 5. Other Information 53

Exhibits

Item 6. Exhibits 54

Signatures

Signatures 55 2 Table of Contents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements NATIONAL HEALTH INVESTORS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share amounts) March 31, 2024 December 31, 2023 (unaudited) Assets: Real estate properties: Land $ 180,749 $ 180,749 Buildings and improvements 2,596,232 2,593,696 Construction in progress 6,389 5,913 2,783,370 2,780,358 Less accumulated depreciation ( 690,790 ) ( 673,276 ) Real estate properties, net 2,092,580 2,107,082 Mortgage and other notes receivable, net of reserve of $ 15,475 and $ 15,476 , respectively 258,874 245,271 Cash and cash equivalents 11,357 22,347 Straight-line rent receivable 84,257 84,713 Assets held for sale, net 5,004 5,004 Other assets, net 26,053 24,063 Total Assets (a) $ 2,478,125 $ 2,488,480 Liabilities and Stockholders' Equity: Debt $ 1,139,266 $ 1,135,051 Accounts payable and accrued expenses 26,782 34,304 Dividends payable 39,082 39,069 Deferred income 5,429 6,009 Total Liabilities (a) 1,210,559 1,214,433 Commitments and contingencies Redeemable noncontrolling interest 9,425 9,656 National Health Investors, Inc. Stockholders' Equity: Common stock, $ 0.01 par value, 100,000,000 shares authorized; 43,424,841 and 43,409,841 shares issued and outstanding, respectively 434 434 Capital in excess of par value 1,605,912 1,603,757 Retained earnings 2,497,791 2,466,844 Cumulative dividends ( 2,856,165 ) ( 2,817,083 ) Total National Health Investors, Inc. Stockholders' Equity 1,247,972 1,253,952 Noncontrolling interests 10,169 10,439 Total Equity 1,258,141 1,264,391 Total Liabilities and Equity $ 2,478,125 $ 2,488,480 (a) The consolidated balance sheets include the following amounts related to our consolidated Variable Interest Entities (VIEs): $ 510.1 million and $ 513.2 million of Real estate properties, net; $ 5.4 million and $ 10.9 million of Cash and cash equivalents;$ 9.7 million and $ 9.7 million of Straight-line rent receivable; $ 9.8 million and $ 9.4 mil

View Full Filing

View this 10-Q filing on SEC EDGAR